Bio-Rad Laboratories, Inc. (BIO)
Trading disclosure
The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for certain activity generated through this link. Prices displayed are informational.
Learn moreKey Executives
| Name | Title | Pay | Exercised | Year Born |
|---|---|---|---|---|
|
Mr. Norman D. Schwartz
|
Chairman & CEO | 1.68M | -- | 1950 |
|
Mr. Jonathan P. DiVincenzo
|
President & COO | 1.17M | -- | 1966 |
|
Mr. Roop K. Lakkaraju CPA
|
Executive VP & CFO | 984.42k | -- | 1971 |
|
Mr. James J. Barry
|
Executive VP & President of Life Science Group | 1.11M | -- | 1978 |
|
Mr. Rajat Mehta
|
Executive Vice President of Global Commercial Operations | 829.47k | -- | 1979 |
|
Mr. Ruben Argueta
|
Vice President of Investor Relations | -- | -- | -- |
|
Matthew Werner
|
Senior VP and Chief Compliance & Privacy Officer | -- | -- | -- |
|
Ms. Courtney C. Enloe
|
Executive VP, General Counsel & Secretary | -- | -- | 1972 |
|
Ms. Nanditha R. Yelamanchi
|
Executive Vice President of Global Human Resources | -- | -- | -- |
|
Mr. Michael Crowley
|
Executive Vice President of Global Commercial Operations | 649.8k | 360.07k | 1962 |
Bio-Rad Laboratories, Inc.
- Sector:
- Healthcare
- Industry: Medical Devices
- Full Time Employees:
- 7,450
Description
Bio-Rad Laboratories, Inc. develops, manufactures, and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, Latin America, and internationally. It operates through two segments, Life Science and Clinical Diagnostics. The Life Science segment develops, manufactures, and markets instruments, systems, reagents, and consumables to separate, purify, characterize, and quantify biological materials, including cells, proteins, and nucleic acids used in research and biopharmaceutical laboratory environments, as well as for biopharmaceutical manufacturing, quality control process, food safety, and science education applications. This segment serves universities and medical schools, industrial research organizations, government agencies, pharmaceutical manufacturers, biotechnology companies, food producers, and testing laboratories. Its Clinical Diagnostics segment designs, manufactures, markets, and supports diagnostic test systems, informatics systems, test kits, and specialized quality controls for clinical, hospital, diagnostic reference, and transfusion and physician office laboratories, as well as software. The company offers its products through its direct commercial organization, as well as through distributors, agents, brokers, and resellers. Bio-Rad Laboratories, Inc. was founded in 1952 and is headquartered in Hercules, California.
Corporate Governance
Upcoming Events
November 4, 2026 at 9:00 PM UTC
Bio-Rad Laboratories, Inc. Earnings Date
Recent Events
May 13, 2026 at 12:00 AM UTC
SD: Specialized Disclosure Report filed pursuant to Section 1502 of the Dodd-Frank Wall Street Reform and Consumer Protection Act relating to the use of conflict minerals (Rule 13p-1)
